Nitroxyl (HNO): A Possible Strategy for Fighting Cancer
Nitroxyl (HNO), the one electron reduced form of nitric oxide (NO), shows a very distinct chemistry and biology from that of NO. Chemical profile is characterized by reactions with thiols and thiol proteins such as aldehyde dehydrogenase, glyceraldehyde 3-phosphate dehydrogenase, caspases
among others. Biological profile of HNO includes cardioprotective actions especially in cases of heart failure. This short review focuses on the cytotoxic properties for HNO. Nitroxyl was found to be toxic to several cancer cell lines including lung and breast cancers. Critical thiols that
control cancer cellular functions might be the target for HNO activity. The anti-tumor actions of HNO donating aspirin is also summarized.
Keywords: Angeli’s salt; Anti-cancer; HNO; IPA/NO-aspirin; Nitric oxide; Nitroxyl
Document Type: Research Article
Publication date: 01 September 2016
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content